Psygen

Psygen is a specialized contract development and manufacturing organization (CDMO) focused on the production of pharmaceutical-grade psychedelic substances. Based in Calgary, Canada, the company holds a Health Canada Dealer's License, allowing for the legal synthesis and distribution of restricted drugs such as LSD, MDMA, psilocybin, and DMT. Psygen's primary mission is to provide high-purity active pharmaceutical ingredients (APIs) to support clinical trials and emerging psychedelic-assisted therapy markets. The company operates a purpose-built facility designed to meet Good Manufacturing Practice (GMP) standards for large-scale chemical synthesis. By securing a robust supply chain for these complex molecules, Psygen enables researchers and drug developers to advance new treatments for mental health conditions. Their expertise spans from process development to commercial-scale manufacturing of controlled small molecules.